Drug Shortage Report for APO-GLICLAZIDE

Last updated on 2020-09-14 History
Report ID 123561
Drug Identification Number 02245247
Brand name APO-GLICLAZIDE
Common or Proper name GLICLAZIDE
Company Name APOTEX INC
Market Status MARKETED
Active Ingredient(s) GLICLAZIDE
Strength(s) 80MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 500 BTL
ATC code A10BB
ATC description BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-08-31
Estimated end date 2020-09-15
Actual end date 2020-09-11
Shortage status Resolved
Updated date 2020-09-14
Company comments
Health Canada comments
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v3 2020-09-14 English Compare
v2 2020-09-02 French Compare
v1 2020-09-02 English Compare